Perivascular innate immune events modulate early murine vein graft adaptations

Journal of Vascular Surgery

Volumn 57, Issue 2, 2013, Pages

  Nguyen, Binh T ^a   Yu, Peng ^a   Tao, Ming ^a   Hao, Shuai ^a   Jiang, Tianyu ^a   Ozaki, C Keith ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; I KAPPA B KINASE BETA; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; GENE EXPRESSION; INFERIOR CAVA VEIN; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VEIN GRAFT;

EID: 84872679975     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.07.007     Document Type: Article

References (33)

1. I. Sabroe, L.C. Parker, S.K. Dower, and M.K. Whyte The role of TLR activation in inflammation J Pathol 214 2008 126 135
2. P.M. Ridker, and J.D. Silvertown Inflammation, C-reactive protein, and atherothrombosis J Periodontol 79 2008 1544 1551
3. C.D. Owens, P.M. Ridker, M. Belkin, A.D. Hamdan, F. Pomposelli, and F. Logerfo Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery J Vasc Surg 45 2007 2 9 discussion: 9
4. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
5. A. Vink, A.H. Schoneveld, J.J. van der Meer, B.J. van Middelaar, J.P. Sluijter, and M.B. Smeets In vivo evidence for a role of Toll-like receptor 4 in the development of intimal lesions Circulation 106 2002 1985 1990
6. S.J. Creely, P.G. McTernan, C.M. Kusminski, M. Fisher, N.F. Da Silva, and M. Khanolkar Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes Am J Physiol Endocrinol Metab 292 2007 E740 E747
7. F. Kim, M. Pham, I. Luttrell, D.D. Bannerman, J. Tupper, and J. Thaler Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity Circ Res 100 2007 1589 1596
8. F. Fischetti, R. Candido, B. Toffoli, P. Durigutto, S. Bernardi, and R. Carretta Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes Atherosclerosis 216 2011 83 89
9. J.C. Karper, M.R. de Vries, B.T. van den Brand, I.E. Hoefer, J.W. Fischer, and J.W. Jukema Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice Arterioscler Thromb Vasc Biol 31 2011 1033 1040
10. C. Hayashi, A.G. Madrigal, X. Liu, T. Ukai, S. Goswami, and C.V. Gudino Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses J Innate Immun 2 2010 334 343
11. H.W. Kaebnick, D.F. Bandyk, T.W. Bergamini, and J.B. Towne The microbiology of explanted vascular prostheses Surgery 102 1987 756 762
12. K.A. Giles, A.D. Hamdan, F.B. Pomposelli, M.C. Wyers, J.J. Siracuse, and M.L. Schermerhorn Body mass index: surgical site infections and mortality after lower extremity bypass from the national surgical Quality Improvement Program 2005-2007 Ann Vasc Surg 24 2010 48 56
13. M. Takaoka, D. Nagata, S. Kihara, I. Shimomura, Y. Kimura, and Y. Tabata Periadventitial adipose tissue plays a critical role in vascular remodeling Circ Res 105 2009 906 911
14. T.K. Chatterjee, L.L. Stoll, G.M. Denning, A. Harrelson, A.L. Blomkalns, and G. Idelman Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding Circ Res 104 2009 541 549
15. K. Sun, C.M. Kusminski, and P.E. Scherer Adipose tissue remodeling and obesity J Clin Invest 121 2011 2094 2101
16. R. Aghamohammadzadeh, S. Withers, F. Lynch, A. Greenstein, R. Malik, and A. Heagerty Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target Br J Pharmacol 165 2012 670 682
17. P. Yu, B.T. Nguyen, M. Tao, C. Campagna, and C.K. Ozaki Rationale and practical techniques for mouse models of early vein graft adaptations J Vasc Surg 52 2010 444 452
18. P. Yu, B.T. Nguyen, M. Tao, Y. Bai, and C.K. Ozaki Mouse vein graft hemodynamic manipulations to enhance experimental utility Am J Pathol 178 2011 2910 2919
19. M.T. Piascik, S.L. Hrometz, S.E. Edelmann, R.D. Guarino, R.W. Hadley, and R.D. Brown Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides J Pharmacol Exp Ther 283 1997 854 868
20. A.V. Schwaiberger, E.H. Heiss, M. Cabaravdic, T. Oberan, J. Zaujec, and D. Schachner Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo Arterioscler Thromb Vasc Biol 30 2010 2475 2481
21. J.R. Hoch, V.K. Stark, D.A. Hullett, and W.D. Turnipseed Vein graft intimal hyperplasia: leukocytes and cytokine gene expression Surgery 116 1994 463 470
22. J.R. Hoch, V.K. Stark, N. van Rooijen, J.L. Kim, M.P. Nutt, and T.F. Warner Macrophage depletion alters vein graft intimal hyperplasia Surgery 126 1999 428 437
23. Z. Jiang, S.A. Berceli, C.L. Pfahnl, L. Wu, D. Goldman, and M. Tao Wall shear modulation of cytokines in early vein grafts J Vasc Surg 40 2004 345 350
24. Z. Jiang, A. Shukla, B.L. Miller, D.R. Espino, M. Tao, and S.A. Berceli Tumor necrosis factor-alpha and the early vein graft J Vasc Surg 45 2007 169 176
25. C.K. Ozaki Cytokines and the early vein graft: strategies to enhance durability J Vasc Surg 45 Suppl A 2007 A92 A98
26. Z. Jiang, P. Yu, M. Tao, C. Ifantides, C.K. Ozaki, and S.A. Berceli Interplay of CCR2 signaling and local shear force determines vein graft neointimal hyperplasia in vivo FEBS Lett 583 2009 3536 3540
27. A. Muto, L. Model, K. Ziegler, S.D. Eghbalieh, and A. Dardik Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies Circ J 74 2010 1501 1512
28. P.L. Faries, M.L. Marin, F.J. Veith, J.A. Ramirez, W.D. Suggs, and R.E. Parsons Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model J Vasc Surg 24 1996 463 471
29. T. Matsuguchi, T. Musikacharoen, T. Ogawa, and Y. Yoshikai Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages J Immunol 165 2000 5767 5772
30. M. Martin, J. Katz, S.N. Vogel, and S.M. Michalek Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli J Immunol 167 2001 5278 5285
31. X. Yang, D. Coriolan, V. Murthy, K. Schultz, D.T. Golenbock, and D. Beasley Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling Am J Physiol Heart Circ Physiol 289 2005 H1069 H1076
32. F.Y. Lin, Y.H. Chen, J.S. Tasi, J.W. Chen, T.L. Yang, and H.J. Wang Endotoxin induces Toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways Arterioscler Thromb Vasc Biol 26 2006 2630 2637
33. O. Pryshchep, W. Ma-Krupa, B.R. Younge, J.J. Goronzy, and C.M. Weyand Vessel-specific Toll-like receptor profiles in human medium and large arteries Circulation 118 2008 1276 1284